American Well Corporation

NYSE:AMWL

Medical - Healthcare Information Services

Healthcare
$11.03 +2.82%

+$0.24 today

Market cap
$171.77M
Beta
1.70
P/E (TTM)
-1.6
EPS (TTM)
-$5.30
52W Low $3.71High $9.96

Volume 0.06M

Average 0.07M

AMWL Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

American Well CorporationNYSE: AMWL

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents falls 19.4% from a year ago

Cash & equivalents stood at $179.21M at the end of Q1 FY2026, down 19.4% from a year earlier and down 1.7% from the prior quarter. Over 3 fiscal years it compounded at -30.3% a year.

Context

  • Cash & equivalents amounted to 55.0% of total assets at the end of Q1 FY2026, up 2.0 pp from a year earlier.
  • Cash & equivalents increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -19.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$179.21M-1.7% QoQ
Last fiscal yearDec 2025
$182.33M-20.1% YoY
Year agoMar 2025
$222.41M-19.4% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-19.4%——
1 year-20.1%——
3-year CAGR-30.3%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
182.33M USD
Year-over-year change
-20.1%
4-year CAGR
-29.7%

Cash & Equivalents vs competitors

How AMWL compares with its peers on the latest reported figures

  • AMWL's Mar 2026 cash & equivalents of $179.21M is the 2nd highest of the 9 companies compared; the peer median is $53.93M.
  • Its year-over-year change of -19.4% is the lowest of 9, against a peer median of +53.3%.
  • Cash & equivalents amounts to 55.0% of total assets for AMWL, versus a peer median of 66.3%.
AMWL Competitors Peer median
Cash & Equivalents for AMWL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IMUXImmunic, Inc.Mar 2026$186.63M +1204.7%-47.5%98.4%
AMWLAmerican Well CorporationMar 2026$179.21M -19.4%-30.3%55.0%
DTILPrecision BioSciences, Inc.Mar 2026$99.37M +28.7%-16.4%69.1%
CAMPCAMP4 Therapeutics CorporationMar 2026$99.21M +101.1%—94.1%
GUTSFractyl Health, Inc. Common StockMar 2026$63.17M +50.0%+18.3%63.6%
BMEABiomea Fusion, Inc.Mar 2026$44.69M +24.6%-20.7%96.4%
ALXOALX Oncology Holdings Inc.Mar 2026$32.28M +56.6%-30.5%18.1%
ATYRaTyr Pharma, Inc.Mar 2026$10.01M -3.4%+2.5%12.6%
EUDAEUDA Health Holdings LimitedJun 2026$365.9K +107.2%+81.7%3.8%
Peer median (excluding AMWL) $53.93M+53.3%-16.4%66.3%

Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents746.42M538.55M372.04M228.32M182.33M
Short-term Investments00000
Net Receivables51.38M58.37M54.15M71.89M49.69M
Inventory7.53M8.74M6.65M2.86M1.19M
Other Current Assets1.7M1.39M16.75M13.93M13.47M
Total Current Assets827.3M626.62M449.58M316.99M246.68M
Property, Plant & Equipment (Net)18.66M14.52M11.03M7.58M4.16M
Goodwill442.76M435.28M000
Intangible Assets152.41M134.98M120.25M101.54M66.07M
Long-term Investments168K795K1.18M1.5M795K
Tax Assets2.03M(795K)000
Other Non-current Assets2.52M6.16M7.67M8.36M6.08M
Total Non-current Assets618.54M590.94M140.12M118.98M77.11M
Total Assets1.45B1.22B589.71M435.97M323.79M
Account Payables12.16M7.24M4.86M5.02M1.65M
Short-term Debt00000
Tax Payables00000
Deferred Revenue68.84M49.51M46.37M53.23M22.63M
Other Current Liabilities83.84M35.97M12.14M36.07M34.73M
Total Current Liabilities141.63M114.06M93.8M111.26M73.21M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)7.06M6.29M6.09M2.78M818K
Other Non-current Liabilities21.59M1.57M1.43M1.17M1.08M
Total Non-current Liabilities43.34M19.65M15.72M8.46M2.79M
Total Liabilities184.96M133.71M109.52M119.72M76M
Common Stock2.62M2.77M145K156K165K
Retained Earnings(811.28M)(1.08B)(1.76B)(1.97B)(2.06B)
Accumulated OCI(6.35M)(16.97M)(15.65M)(15.84M)(12.1M)
Other Stockholders Equity00000
Minority Interest21.62M19.97M15.97M11.47M12.21M
Total Equity1.26B1.08B480.19M316.24M247.79M
Total Debt16.61M14.84M11.79M8.2M4.52M
Net Debt(729.8M)(523.7M)(360.25M)(220.12M)(177.8M)

American Well Corporation

NYSE:AMWL

Intrinsic Alpha fair value

Locked

Current Price

$11.03

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.